Proton NMR examination of tumor cells of high or low metastatic potential

Springer Science and Business Media LLC - Tập 5 - Trang 259-274 - 1987
Steven D. Bines1, Stephen P. Tomasovic2, James W. Frazer3, Joseph Leveque3, Arthur W. Boddie3, Lawrence Dennis4
1Department of General Surgery, Rush-Presbyterian St. Luke's Medical Center, Chicago
2Department of Tumor Biology, UTSCC-M. D. Anderson Hospital and Tumor Institute, Houston, U.S.A.
3Experimental Surgery Section, Department of General Surgery, Houston, U.S.A.
4Baytown Research and Development Division, Exxon Research and Engineering Company, Baytown, U.S.A.

Tóm tắt

Three rat 13762NF mammary adenocarcinoma clones and cell lines of different metastatic potentials (MTLn3, MTC, and MTPa) were studied for their proton nuclear magnetic resonance spectral characteristics as intact cells in vitro and after chloroform/methanol, neuraminidase, or ethanol treatments. The intact-cell spectral characteristics of the highly metastatic tumor cell clone MTLn3 were clearly distinguished from the less metastatic clone MTC or the parental MTPa cell line on the basis of spectral peaks in the range of 0·9 to 1·45 p.p.m. broad peaks near 2·0 p.p.m., and peaks in the range of 2·75 to 3·2 p.p.m. Glycoproteins are among the molecules known to have resonances in these upfield spectral regions, and these tumor cell subpopulations have previously been shown to possess characteristic quantitative differences in cell surface, metastasis-associated glycoproteins. Treatment of the cells with neuraminidase or ethanol, or extraction with chloroform/methanol increased spectral detail and also revealed characteristic differences in spectral peaks between the tumor cell subpopulations. The identity of the cellular components responsible for these spectral characteristics are unknown, but some clearly arise from differences in the extractable lipids present in the tumor cell subpopulations. Further study will be required to determine if the spectral differences described in this preliminary report are directly related to the known biochemical characteristics of the highly metastatic clone, and if the observations have general relevance to metastatic potential or are a singular feature of these cells. However, these initial results suggest that manipulation of factors which allow unmasking of spectral detail combined with the use of prescribed tumor cell subpopulations may aid in using proton NMR to identify and define biochemical or structural differences related to the metastatic potential of tumor cells.

Tài liệu tham khảo

Bines, S. D., Tomasovic, S. P., Frazer, J., and Boddie, A. W., Jr, 1984, Differences in chemical shift of water in pellets of tumor cell clones of defined metastatic potential. Physiologist, 27, 264. Bines, S. D., Tomasovic, S. P., Frazer, J., and Boddie, A. W., jrJr, 1985, Differences in NMR spectra of tumor cell clones of defined metastatic potential. Journal of Surgical Research, 38, 546–552. Brunson, K. W., Beattie, G., and Nicolson, G. L., 1978, Selection and altered tumor cell properties of brain-colonizing metastatic melanoma. Nature, 272, 543–545. Brunson, K. W., and Nicolson, G. L., 1978, Selection and biologic properties of malignant variants of a murine lymphosarcoma. Journal of the National Cancer Institute, 61, 1499–1502. Brunson, K. W., and Nicolson, G. K., 1979, Selection of malignant melanoma variant cell lines for ovary colonization. Journal of Supramolecular Structure, 11, 517–528. Chapman, D., and Salsbury, N. J., 1970, Nuclear magnetic resonance studies of lipids, lysoproteins and cell membranes. Recent Progress in Surgical Science, 3, 121–168. Damadian, R., 1970, Tumor detection by nuclear magnetic resonance. Science, 171, 1151–1153. Fidler, I. J., 1973, Selection of successive tumor lines for metastasis. Nature New Biology, 242, 148–149. Folch, J., 1942, Brain cephalin, a mixture of phosphatides. Separation from it of phosphatidyl serine, phosphatidyl ethanolamine, and a fraction containing an inositol phosphatide. Journal of Biological Chemistry, 146, 35–44. Folch, J., Ascoli, L., Lees, M., Meath, J. A., and Lebaron, F. N., 1951, Separation of lipid extracts from brain tissue. Journal of Biological Chemistry, 191, 833–841. Harris, R. K., 1983, Nuclear Magnetic Resonance Spectroscopy, A Physiochemical View (Boston, Mass: Pitman Publishing Company), pp. 86–94. Hazlewood, C. F., Chang, D. C., Medina, D., Cleveland, G., and Nichols, B. L., 1972, Distinction between the preneoplastic and neoplastic state of murine mammary glands. Proceedings of the National Academy of Sciences, U.S.A., 69, 1478–1480. Koutcher, J. A., Goldsmith, M., and Damadian, R., 1978, NMR in cancer: A malignancy index to discriminate normal and cancerous tissue. Cancer, 41, 174–182. McLaughlin, A. C., Cullen, P. R., Hemminga, M., Brown, F. F., and Brocklehurst, J., 1977, Magnetic resonance studies of model and biologic membranes. NMR in Biology (New York: Academic Press), pp. 230–246. Mountford, C. E., Grossman, G., Reid, G., and Fox, R. M., 1982, Characterization of transformed cells and tumors by proton nuclear magnetic resonance spectroscopy. Cancer Research, 42, 2270–2276. Mountford, C. E., Holmes, K. T., and Smith, I. C. P., 1986, NMR analysis of cancer cells. Progress in Clinical Biochemistry and Medicine, 3, 75–112. Mountford, C. E., MacKinnon, W. B., Bloom, M., Burnell, E. E., and Smith, C. P., 1984, NMR methods for characterizing the state of the surfaces of complex mammalian cells. Journal of Biochemical and Biophysical Methods, 9, 323–330. Mountford, C. E., Wright, C. C., Holmes, K. T., MacKinnon, W. B., Gregory, P., and Fox, R. M., 1984, High resolution proton nuclear magnetic resonance analysis of metastatic cancer cells. Science, 226, 1415–1417. Nakajima, M., Welch, D. R., Irimura, T., and Nicolson, G. L., 1986, Basement membrane degradative enzymes as possible markers of tumor metastasis. Cancer Metastatis: Experimental and Clinical Strategies, edited by D. Welch, B. K. Bhuyon and L. A. Liotta (New York: Alan R. Liss), pp. 113–122. Neri, A., Welch, D., Kawaguchi, T., and Nicolson, G. L., 1982, Development and biologic properties of malignant cell sublines and clones of a spontaneously metastasizing rat mammary adenocarcinoma. Journal of the National Cancer Institute, 68, 507–517. Nicolson, G. L., 1982, Cancer metastasis: Organ colonization and the cell surface properties of malignant cells. Biochimica et Biophysica Acta, 695, 113–176. Owens, A. H., Coffey, D. S., and Baylin, S. B. (editors), 1982, Tumor Cell Heterogeneity. Origins and Implications (New York: Academic Press). Ranade, S. S., Shah, S., and Talwalker, G. V., 1979, Histopathological evidence in support of the association of elevated proton spin-lattice relaxation times with the malignant state. Tumor, 65, 157–162. Reading, C. L., Brunson, K. W., Torrianni, M., and Nicolson, G. L., 1980, Malignancies of metastatic murine lymphosarcoma cell lines and clones correlate with decreased cell surface display of RNA tumor virus envelope glycoprotein gp70. Proceedings of the National Academy of Sciences, U.S.A., 77, 5943–5947. Rorschach, H. E., and Hazlewood, C. F., 1986, Protein dynamics and the NNIR relaxation time T 1 of water in biological systems. Journal of Magnetic Resonance, 70, 79–88. Roth, K., 1984, NMR Tomography and Spectroscopy in Medicine (New York: Springer-Verlag). Segaloff, A., 1966, Hormones and breast cancer. Recent Progress in Hormone Research, 22, 351–379. Smith, R. L., and Oldfield, E., 1984, Dynamic structure of membranes by deuterium NMR. Science, 225, 280–288. Steck, P. A., and Nicolson, G. L., 1983, Cell surface glycoproteins of 13762NF mammary adenocarcinoma clones of differing metastatic potential. Experimental Cell Research, 147, 255–267. Steck, P. A., and Nicolson, G. L., 1984, Cell surface properties of spontaneously metastasizing rat mammary adenocarcinoma cell clones. Transplantation Proceedings, 16, 355–360. Steck, P. A., and Nicolson, G. L., 1984, Isolation and analysis of a cell surface metastasis-associated sialogalactoprotein from rat and human mammary adenocarcinoma. Treatment of Metastasis: Problems and Prospects, edited by K. Hellmann and S. A. Eccles (London, Philadelphia: Taylor & Francis), pp. 101–111. Steck, P. A., and Nicolson, G. L., 1987, Purification and partial characterization of a tumor metastasis-associated high-Mr glycoprotein from rat 13762NF mammary adenocarcinoma cells. Biochemical Journal, 242, 779–787. Tao, T. W., Maller, A., Vogel, K., and Burger, M. M., 1976, Liver colonizing melanoma cells selected from B16 melanoma. International Journal of Cancer, 23, 854–857. Welch, D. R., Neri, A., and Nicolson, G. L., 1983, Comparison of ‘spontaneous’ and ‘experimental’ metastasis using rat 13762 mammary adenocarcinoma metastatic cell clones. Invasion and Metastasis, 3, 65–80. Welch, D. R., and Tomasovic, S. P., 1985, Implications of tumor progression on clinical oncology. Clinical and Experimental Metastasis, 3, 151–188. Withrich, K., 1976, NMR in Biological Research: Peptides and Proteins (New York: American Elsevier), pp. 15–56, 65–122. Wieczorek, A. J., Rhymer, C., and Block, L. H., 1985, Isolation and characterization of an RNA-proteolipid complex associated with the malignant state in humans. Proceedings of the National Academy of Sciences, U.S.A., 82, 3455–3459. Wright, L. C., May, G. L., Dyne, M., and Mountford, C. E., 1986, A proteolipid in cancer cells is the origin of their high-resolution NMR spectrum. FEBS Letters, 203, 164–168.